Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dimethicone + fluocinonide
- Development stage
- Unknown
- Lead developer
- Valeant Pharmaceuticals
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Administration
- Topical
01
Overview
This combination is a topical preparation. **Fluocinonide** is a strong topical corticosteroid used to treat skin conditions such as eczema, psoriasis, and dermatitis by reducing inflammation and symptoms like redness, itching, and swelling. **Dimethicone** is an emollient used to moisturize and protect the skin. Together, they help relieve skin irritation while maintaining skin hydration.
- Brand names
- Fluopar
02
Targets
ESRRA (Estrogen-related receptor alpha)ESRRB (Estrogen-related receptor beta)ESRRG (Estrogen-related receptor gamma)GR (Glucocorticoid receptor)SMO (Smoothened)
Beyond the preview
Go deeper on dimethicone + fluocinonide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dimethicone + fluocinonide.